Filings

6 documents · 58 matches

1. TLPH TALPHERA, INC. 10-Q 2026-08-12

   Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

   tariffs on products imported from outside the United States, including specific tariffs on pharmaceutical products, which will likely increase our cost
   10 matches in this document Show context Copy citation

2. TLPH TALPHERA, INC. 10-Q 2026-05-13

   Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

   tariffs on products imported from outside the United States, including specific tariffs on pharmaceutical products, which will likely increase our cost
   10 matches in this document Show context Copy citation

3. TLPH TALPHERA, INC. 10-K 2026-03-23

   Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations

   tariffs on products imported from outside the United States, including specific tariffs on pharmaceutical products, which will likely increase our cost
   10 matches in this document Show context Copy citation

4. TLPH TALPHERA, INC. 10-Q 2025-11-12

   Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

   tariffs on products imported from outside the United States, including specific tariffs on pharmaceutical products, which will likely increase our cost
   10 matches in this document Show context Copy citation

5. TLPH TALPHERA, INC. 10-Q 2025-08-14

   Item 1A. Risk Factors

   tariffs will result in increased research and development expenses, including with respect to increased costs associated with APIs, raw materials
   9 matches in this document Show context Copy citation

6. TLPH TALPHERA, INC. 10-Q 2025-05-14

   Item 1A. Risk Factors

   tariffs will result in increased research and development expenses, including with respect to increased costs associated with APIs, raw materials
   9 matches in this document Show context Copy citation